Velcades approval i MM:
-
Velcades approval i MM:
http://theoncologist.alphamedpress.org/content/8/6/508.shortRevlimids approval i MM:
http://www.cancer.gov/cancertopics/druginfo/fda-lenalidomideSingle agent Revlimid:
http://www.ncbi.nlm.nih.gov/pubmed/19471019Single agent Velcade:
http://www.ncbi.nlm.nih.gov/pubmed/18763595Alt i alt vil 25-40% ORR være meget GOD for Daratumumab (mono) i relapsed eller refrac. patienter og mere vil være SUPER.
En gruppe af MM patienter relapser hurtigt og for dem er der ikke sket fremskridt i behandlingen i årevis.
Hvis Daratumumab kan give dem en længerevarende respons er approval ligefor !
...slut med dara herfra
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind